Clinical Trials Directory

Trials / Completed

CompletedNCT05967845

Platelet Rich Fibrin Augmented Tympanoplasty Versus Cartilage Tympanoplasty

Platelet Rich Fibrin Augmented Tympanoplasty Versus Cartilage Tympanoplasty: a Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
156 (actual)
Sponsor
Mansoura University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study was performed to compare healing and hearing outcomes of two tympanoplasty techniques, performed for patients with total or subtotal tympanic membrane perforations. The first group underwent temporalis fascia tympanoplasty, augmented with platelet rich fibrin, while the second group underwent cartilage tympanoplasty. preoperative data, operative techniques, and postoperative outcomes were analyzed.

Detailed description

Two groups are included. In the platelet rich fibrin augmented tympanoplasty group, a piece of temporalis fascia is harvested and used as a graft material. A layer of platelet rich fibrin is added to improve healing process. In the cartilage tympanoplasty group, a piece of cartilage is harvested from the patient concha and used for grafting. Both groups will be compared in terms of healing and hearing. Healing is considered successful if an intact tympanic membrane is achieved withing 12 weeks follow up period. Hearing outcomes are analyzed by comparing the preoperative pure tone audiometry values with the postoperative values.

Conditions

Interventions

TypeNameDescription
PROCEDUREcartilage tympanoplastycartilage tympanoplasty procedure entails repairing the tympanic membrane perforation by using a piece of cartilage harvested from the patient's auricle.
PROCEDUREplatelet rich fibrin augmented tympanoplastyplatelet rich fibrin augmented tympanoplasty entails performing the traditional tympanoplasty using the tempralis fascia as a grafting material. However, platelet rich fibrin clot is obtained from the patient's own blood, and applied to the graft to enhance healing process.

Timeline

Start date
2019-01-01
Primary completion
2022-12-31
Completion
2022-12-31
First posted
2023-08-01
Last updated
2023-08-01

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05967845. Inclusion in this directory is not an endorsement.